Evidence map›Paper›PMID 14736338›Full record

ArticleBMC cell biology2004

Sam68 exerts separable effects on cell cycle progression and apoptosis.

Stephen J Taylor, Ross J Resnick, David Shalloway

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 101 citations in OpenAlex.

  1. Role of Sam68 in different types of cancer (Review).International journal of molecular medicine · 2025
    Review
  2. Article
  3. Article
  4. Structure, Function, and Regulation of the SRMS Tyrosine Kinase.International journal of molecular sciences · 2020
    Review
  5. Leptin, Adiponectin, and Sam68 in Bone Metastasis from Breast Cancer.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  13. Article
  14. Article
  15. Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  16. Clinical significance of Sam68 expression in endometrial carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  17. Article
  18. Review
  19. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Stephen J TaylorDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA. suburbantrain@yahoo.com
Ross J Resnick
David Shalloway
Cornell University · USUniversity of California, Berkeley · US

Funding

Src and PTPalpha in signal transduction and cancerR01CA032317 · NCI · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI SHALLOWAY, DAVID I. · 1985 to 2007
$3.5M
NCI NIH HHS CA32317NCI NIH HHS R01 CA032317
6 · The paper itself

Abstract

backgroundThe RNA-binding protein Sam68 has been implicated in a number of cellular processes, including transcription, RNA splicing and export, translation, signal transduction, cell cycle progression and replication of the human immunodeficiency virus and poliovirus. However, the precise impact it has on essential cellular functions remains largely obscure.

resultsIn this report we show that conditional overexpression of Sam68 in fibroblasts results in both cell cycle arrest and apoptosis. Arrest in G1 phase of the cell cycle is associated with decreased levels of cyclins D1 and E RNA and protein, resulting in dramatically reduced Rb phosphorylation. Interestingly, cell cycle arrest does not require the specific RNA binding ability of Sam68. In marked contrast, induction of apoptosis by Sam68 absolutely requires a fully-functional RNA binding domain. Moreover, the anti-cancer agent trichostatin A potentiates Sam68-driven apoptosis.

conclusionsFor the first time we have shown that Sam68, an RNA binding protein with multiple apparent functions, exerts functionally separable effects on cell proliferation and survival, dependent on its ability to bind specifically to RNA. These findings shed new light on the ability of signal transducing RNA binding proteins to influence essential cell function. Moreover, the ability of a class of anti-cancer therapeutics to modulate its ability to promote apoptosis suggests that Sam68 status may impact some cancer treatments.

Indexed as

ApoptosisCell CycleAdaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell DivisionMiceNIH 3T3 CellsRNARNA-Binding ProteinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsKhdrbs1 protein, mouseRNARNA-Binding Proteins

Identifiers

PMID14736338
PMCPMC331397
OpenAlexW1773463278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.